ATH 0.00% 0.5¢ alterity therapeutics limited

Any news ??, up in NY 8%, page-12

  1. 1,494 Posts.
    lightbulb Created with Sketch. 93
    Hi Rebecca,

    Don’t mean to be rude, but Exchanger is correct, your statement is very misleading. The Biomuse study was only still finishing enrollment recently ( 80% complete as per last quarterly report) and the study will be ongoing for 12 months as per the slides from the 10th March Global life Science conference. This means the study will not be completed until mid next year. I suggest you re read page 19 of that report which clearly shows Phase 2 commencement will begin later this year and run simultaneously with the trial.

    The trial will definitely start before the completion of the study. FDA will use that information to help Alterity extract endpoints - as it was at their suggestion they do this Biomuse study in the first place by my recollection.

    https://hotcopper.com.au/data/attachments/3236/3236869-41ad22b8ca7f9d037bc518a0a670cf14.jpg







    Last edited by pierre77: 03/06/21
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $993 198.5K

Buyers (Bids)

No. Vol. Price($)
43 39471212 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 15794717 21
View Market Depth
Last trade - 10.29am 27/05/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.000 ( 9.09 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 3509722
Last updated 11.16am 27/05/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.